SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
West Partners, the investment arm of the Gary & Mary West Family Office, said Tuesday it had become a majority investor in Omaha-based Javlin Capital.
Human Longevity Inc. (HLI), a tech-driven genomics company founded and led by geneticist J. Craig Venter, made some changes and additions to its leadership team.
GlySens Inc., a local company that manufacturers glucose monitoring systems, celebrated the grand opening of its new corporate headquarters March 31.
Property owner BioMed Realty announced that it has fully leased its 316,000-square-foot i3 campus, currently under construction at University Town Center, to biotech company Illumina Inc.
Human Longevity Inc. (HLI), a tech-driven genomics company founded and led by pioneering geneticist J. Craig Venter, has raised $220 million in stock offering.
Los Angeles-based Convalo Health International Corp., a company providing addiction recovery services, has opened an outpatient behavioral health and addiction recovery center (known as an IOP center) in San Diego.
San Diego drugmaker Conatus Pharmaceuticals Inc., focused on liver disease drugs, announced the appointment of Edward F. Smith III as senior vice president of regulatory affairs and quality assurance.
San Diego drugmaker Adamis Pharmaceuticals, which makes low-cost alternatives to expensive drugs, is acquiring Conway, Arkansas-based US Compounding Inc.
San Diego-based Toft Group, an executive search firm building leadership teams for life sciences and health care companies, announced the opening of a new office in South San Francisco.
aTyr Pharma, Inc., a biotherapeutics company in San Diego, announced fourth quarter and full-year earnings, along with the appointment of a new company executive.
BIOTECH: Trovagene Firings Raise Questions Over Roles
Is Trovagene Inc. a diagnostic or a therapeutic company?
Zavante Therapeutics, a San Diego startup quietly launched by big-shot biotech veterans last fall, has raised $45 million to fund development of its lead drug.
Trovagene Inc. has fired and sued two of its top executives — CEO Antonius Schuh and CFO Stephen Zaniboni -- alleging breach of fiduciary duty. The actions caught both seasoned biotech executives by surprise.
The Food and Drug Administration's panel of advisers voted 12-2 Tuesday in favor of an experimental drug from ACADIA Pharmaceuticals, saying its benefits outweigh the risks.
Trovagene’s shares are down 12 percent Tuesday after the maker of liquid biopsies said it fired and sued its chief executive officer and chief financial officer.